S
0.310
-0.01 (-3.13%)
前收盘价格 | 0.320 |
收盘价格 | 0.320 |
成交量 | 106,662 |
平均成交量 (3个月) | 47,601 |
市值 | 66,993,480 |
价格/销量 (P/S) | 0.610 |
股市价格/股市净资产 (P/B) | 2.17 |
52周波幅 | |
利润日期 | 28 Aug 2024 |
营业毛利率 | -13.36% |
营业利益率 (TTM) | -8.16% |
稀释每股收益 (EPS TTM) | -0.100 |
季度收入增长率 (YOY) | 6.60% |
总债务/股东权益 (D/E MRQ) | 14.93% |
流动比率 (MRQ) | 1.76 |
营业现金流 (OCF TTM) | -6.33 M |
杠杆自由现金流 (LFCF TTM) | -6.86 M |
资产报酬率 (ROA TTM) | -7.86% |
股东权益报酬率 (ROE TTM) | -36.31% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (AU) | 混合的 | 混合的 |
Medical Devices (全球的) | 混合的 | 混合的 | |
股票 | SOMNOMED FPO [SOM] | - | - |
AIStockmoo 评分
0.5
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | -2.0 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 4.0 |
平均 | 0.50 |
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Value |
内部持股比例 | 13.90% |
机构持股比例 | 56.32% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合